Best practice in reporting corona studies: Minimum information about Nanomaterial Biocorona Experiments (MINBE).

Characterisation of the adsorption of biomolecules, or a biocorona, on nanomaterials has proliferated in the past 10 years, as protein corona studies provide molecular level insight into mechanisms of cellular recognition, uptake, and toxicity of nanomaterials. At the crossroads of two rapidly evolving orthogonal fields, nanoscience and proteomics, the interdisciplinarity of protein corona studies creates challenges for experimental design and reporting. Here we propose a flexible checklist for experimental design and reporting guidelines to outline Minimum Information about Nanomaterial Biocorona Experiments (MINBE). The checklist for experimental design, compiled after review of reporting within the protein corona literature, provides researchers with prompts to ensure best practice experimental approaches for each stage of the workflow, collated from the nanoscience, proteomics, and bioinformatics fields. Reporting guidelines are also assembled from established sources, integrated to span the entire workflow and extended and modified to aid interdisciplinary researchers in the most challenging stages of the workflow. Where appropriate, de novo guidelines to address areas specific to protein corona studies, including exposure conditions and isolation of adsorbed proteins, were written. The MINBE guidelines provide protein corona researchers with a conduit between materials science techniques and proteomics. Implementation of these guidelines is anticipated to catalyse enhanced quality, impact, and extent of data mining and computational modelling of protein corona composition and its role in nanosafety and nanomedicine. Furthermore, high quality experimental design and reporting in the bio-nanosciences will enhance the next phase of targeted nanomedicines and sustainable nanotechnologies.

[1]  A. Doucet-Panaye,et al.  Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches , 2016, SAR and QSAR in environmental research.

[2]  Nigel W. Hardy,et al.  Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project , 2008, Nature Biotechnology.

[3]  Edmund J. Crampin,et al.  Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.

[4]  Maryam Mobed-Miremadi,et al.  Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties. , 2018, Environmental science. Nano.

[5]  Thomas N. Lawson,et al.  Metabolomic method to detect a metabolite corona on amino-functionalized polystyrene nanoparticles , 2019, Nanotoxicology.

[6]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[7]  Rigoberto Hernandez,et al.  Biological Responses to Engineered Nanomaterials: Needs for the Next Decade , 2015, ACS central science.

[8]  Lennart Martens,et al.  The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.

[9]  Birgit Schilling,et al.  Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. , 2010, Journal of proteome research.

[10]  Stefan Tenzer,et al.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.

[11]  M. Mortimer,et al.  NanoEHS beyond Toxicity - Focusing on Biocorona. , 2017, Environmental science. Nano.

[12]  Lennart Martens,et al.  Quality control in mass spectrometry-based proteomics. , 2018, Mass spectrometry reviews.

[13]  Ju Yong Lee,et al.  Analysis of lipid adsorption on nanoparticles by nanoflow liquid chromatography-tandem mass spectrometry , 2018, Analytical and Bioanalytical Chemistry.

[14]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[15]  N. Verma,et al.  Identification and characterization of small organic compounds within the corona formed around engineered nanoparticles , 2018 .

[16]  Andrew J Chetwynd,et al.  Corona Isolation Method Matters: Capillary Electrophoresis Mass Spectrometry Based Comparison of Protein Corona Compositions Following On-Particle versus In-Solution or In-Gel Digestion , 2019, Nanomaterials.

[17]  Mei-Ling Cheng,et al.  Fatty acids and small organic compounds bind to mineralo-organic nanoparticles derived from human body fluids as revealed by metabolomic analysis. , 2016, Nanoscale.

[18]  Martin Eisenacher,et al.  Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. , 2013, Journal of proteomics.

[19]  K. Landfester,et al.  Beyond the protein corona - lipids matter for biological response of nanocarriers. , 2018, Acta biomaterialia.

[20]  Morteza Mahmoudi,et al.  Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies. , 2018, Trends in biotechnology.

[21]  Philip B. Stark,et al.  Before reproducibility must come preproducibility , 2018, Nature.

[22]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[23]  Stefan Tenzer,et al.  Quantitative profiling of the protein coronas that form around nanoparticles , 2014, Nature Protocols.

[24]  S. Stolte,et al.  Changing environments and biomolecule coronas: consequences and challenges for the design of environmentally acceptable engineered nanoparticles , 2018 .

[25]  Warren C W Chan,et al.  Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.

[26]  Wolfgang J Parak,et al.  A Decade of the Protein Corona. , 2017, ACS nano.

[27]  Chris F. Taylor,et al.  Guidelines for reporting the use of mass spectrometry informatics in proteomics , 2008, Nature Biotechnology.

[28]  Jim X. Shen,et al.  A novel and cost effective method of removing excess albumin from plasma/serum samples and its impacts on LC-MS/MS bioanalysis of therapeutic proteins. , 2014, Analytical chemistry.

[29]  Chris F. Taylor,et al.  Guidelines for reporting the use of mass spectrometry in proteomics , 2008, Nature Biotechnology.

[30]  Ronald J. Moore,et al.  Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size , 2011, Proteomics.